Stocks and Investing
Stocks and Investing
Thu, June 13, 2024
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
[ Thu, Jun 13th 2024
] - WOPRAI
Brandon Folkes Initiated (TRVI) at Strong Buy and Held Target at $7 on, Jun 13th, 2024
Brandon Folkes of Rodman & Renshaw, Initiated "Trevi Therapeutics, Inc." (TRVI) at Strong Buy and Held Target at $7 on, Jun 13th, 2024.
Brandon has made no other calls on TRVI in the last 4 months.
There are 2 other peers that have a rating on TRVI. Out of the 2 peers that are also analyzing TRVI, 0 agree with Brandon's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Brandon
- Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $8 on, Wednesday, May 8th, 2024
- Leland Gershell of "Oppenheimer" Maintained at Buy and Held Target at $9 on, Thursday, March 21st, 2024
Contributing Sources